STAA
STAAR Surgical Company
20.50$
+7.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.0% | +1.4% | +28.0% | -10.5% | -44.7% | -13.0% | +4.1% | +113.7% | -39.0% | +61.8% | +0.0% | – | |
| – | -6.7% | +5.0% | +26.2% | -2.4% | -13.9% | -15.7% | -21.0% | +46.3% | -16.6% | +84.9% | -8.4% | – | |
| – | -4.6% | +0.5% | +28.5% | -12.7% | -53.8% | -11.5% | +17.1% | +137.4% | -43.8% | +54.4% | +3.3% | – | |
| – | -5.3% | +23.1% | -11.3% | +22.2% | -16.9% | +13.5% | -24.9% | -10.3% | +0.4% | +5.1% | +2.3% | – | |
| – | -12.5% | +37.8% | +1.8% | -8.3% | -1.6% | +14.6% | -14.3% | -1.0% | -5.6% | -13.1% | +33.6% | – | |
| – | -12.2% | +25.8% | +5.1% | -5.6% | -5.2% | +43.4% | -26.5% | -5.4% | -7.9% | -8.3% | +19.0% | – | |
| – | +65.3% | -121.9% | – | -52.2% | -591.2% | – | – | – | -159.1% | – | -42.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +103.7% | -116.1% | – | +27.3% | -330.5% | – | – | – | -209.9% | – | +34.1% | – | |
| – | +210.2% | -81.1% | +162.0% | +7.6% | +22.5% | -107.1% | – | – | -123.7% | – | -1.5% | – | |
| – | +61.0% | -143.1% | – | +35.2% | -443.0% | – | – | – | -306.1% | – | +54.8% | – | |
| – | +84.8% | -106.5% | – | +25.8% | -287.4% | – | – | – | -169.0% | – | +28.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.